Biopol Chemicals Ltd (BIOPOL) Quarterly Report Analysis & Insights

Biopol Chemicals Ltd

| Audited Financial Results for the Half Year and Year Ended March 31, 2026

⬤30th Apr 26

Summary : Biopol Chemicals reported strong FY26 financial results with significant revenue and profit growth, an unmodified audit opinion, and ongoing capital expansion.

Quarterly Report Analysis & Insights

Financial Disclosures

Cost of Material Consumed: 4,370.72 Lakhs (FY26).
Purchases of Stock in Trade: 2,158.14 Lakhs (FY26).
Employee Benefit Expenses: 178.85 Lakhs (FY26).
Finance Costs: 152.08 Lakhs (FY26).
Depreciation and Amortization Expenses: 9.83 Lakhs (FY26).
Other Expenses: 280.53 Lakhs (FY26).
Revenue from Operations: 8,114.33 Lakhs (FY26), 4,922.13 Lakhs (FY25).
Net cash used in Operating Activities: (1,276.60) Lakhs (FY26).
Net cash used in Investing Activities: (1,452.98) Lakhs (FY26).
Net cash generated from Financing Activities: 2,666.58 Lakhs (FY26).
Net increase in cash and cash equivalents: (62.99) Lakhs (FY26).
Share Capital: 1,080.54 Lakhs (FY26), 791.10 Lakhs (FY25).
Reserves and Surplus: 3,911.55 Lakhs (FY26), 567.79 Lakhs (FY25).
Long-term Borrowings: 505.55 Lakhs (FY26), 64.01 Lakhs (FY25).
Short-term Borrowings: 340.94 Lakhs (FY26), 704.52 Lakhs (FY25).
Property, Plant and Equipment: 1,423.84 Lakhs (FY26), 25.45 Lakhs (FY25).
Inventories: 1,960.76 Lakhs (FY26), 1,181.44 Lakhs (FY25).
Trade Receivables: 2,778.69 Lakhs (FY26), 1,665.64 Lakhs (FY25).
Cash and Cash Equivalents: 51.84 Lakhs (FY26), 114.83 Lakhs (FY25).
Remuneration Payable to Managing Director, Spouse, Whole-time Director, CFO, Company Secretary.
Unsecured Loan Accepted and Repaid from Managing Director.
Audited Standalone Financial Results.

Corporate Overview

Registered Office: Ahmedabad, Gujarat, India.
Head Office: New Town, West Bengal, India.
Operates in a single business segment.
Operates in a single business segment.
Formal and compliant, reporting financial results and board approvals.
Purchase of Property, Plant and Equipment (1,407.99 Lakhs) and Capital Work-in-progress (12.00 Lakhs) in FY26.

Risk Factors

Negative cash flow from operating activities.
Significant cash outflow for investing activities.
High reliance on financing for growth.
Company operates in a single business segment.

Key Drivers

Revenue from operations significantly increased.
Profit for the period more than doubled.
Statutory auditors issued unmodified opinion.
Company undertaking capital expansion projects.

Auditor’s Report

Unmodified opinion on the financial results.

Board Commentary

No investor complaints received/pending as on March 31, 2026.
Approved Audited Standalone Financial Results for FY26.
Purchase of Property, Plant and Equipment (1,407.99 Lakhs) and Capital Work-in-progress (12.00 Lakhs).

Corporate Governance

Audit Committee reviewed and recommended financial results.

Management Discussion & Analysis

Performance Drivers

Significant increase in revenue from operations and profit for the period year-on-year.